Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study
Status:
Completed
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A randomized, open-label trial comparing Medihoney Derma Cream to Hydrocortisone 1% cream.
Children between the ages of 2-18 years old diagnosed with mild to moderate atopic dermatitis
with an IGA (Investigator Global Assessment) score of 2-3, and a BSA (Body Surface Area)
score of 1%-10% were included.